NCT07042802 2026-03-06
A Phase Ib/â…¡ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Recruiting
Nanjing Leads Biolabs Co.,Ltd
BioInvent International AB
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Roswell Park Cancer Institute